DAMORA THERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $257.6M | $14.2M | $21.5M | $32.8M | $62.6M | $163.6M | $11.3M | $31.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $260.4M | $16.8M | $36.8M | $63.9M | $110.1M | $169.3M | $56.1M | — |
| Property, Plant & Equipment | $36.0K | $57.0K | $78.0K | $357.0K | $203.0K | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $260.5M | $17.1M | $38.2M | $73.2M | $122.2M | $171.6M | $56.6M | — |
| Liabilities | ||||||||
| Accounts Payable | $444.0K | $377.0K | $1.7M | $3.4M | $1.5M | $2.9M | $3.3M | — |
| Total Current Liabilities | $20.1M | $1.2M | $5.8M | $11.1M | $4.5M | $5.6M | $7.9M | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $20.1M | $1.3M | $5.9M | $11.4M | $5.0M | $6.1M | $8.1M | — |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-487.4M | $-277.5M | $-256.1M | $-217.7M | $-156.1M | $-104.4M | $-69.5M | — |
| Total Stockholders' Equity | $240.4M | $15.8M | $32.3M | $61.8M | $117.2M | $165.5M | $-71.1M | $-33.8M |